A retrospective study of multiple sclerosis in Siriraj Hospital, Bankok, Thailand

Canadian Journal of Neurological Sciences

Volumn 34, Issue 1, 2007, Pages 99-104

  Siritho, Sasitorn ^a   Prayoonwiwat, Naraporn ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; INTERFERON; METHYLPREDNISOLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID CYTOLOGY; CLINICAL STUDY; CONTROLLED STUDY; DEMOGRAPHY; DRUG WITHDRAWAL; FAMILY HISTORY; FEMALE; FEVER; HUMAN; INJECTION SITE REACTION; LEUKOPENIA; LIPODYSTROPHY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYALGIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELAPSE; THAILAND; UNIVERSITY HOSPITAL; VISUAL IMPAIRMENT;

EID: 33947268488     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100005874     Document Type: Article

References (37)

1. Compston A, Coles A. Multiple sclerosis. Lancet. 2002; 359: 1221-31.
2. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Eng J Med. 2000; 343: 938-52.
3. Weinshenker BG. Natural history of multiple sclerosis. Ann Neurol. 1994; 36(Suppl): S6-11.
4. Lublin FD, Reigngold SC. Defining the clinical course of multiple sclerosis: results of international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996; 46: 907-11.
5. Shibasaki H, McDonald WI, Kuroiwa Y. Racial modification of clinical picture of multiple sclerosis. J Neurol Sci. 1981; 49: 253-71.
6. Li PCK, Ong B, Lee KH, Prayoonwiwat N, Tan CT, Tsai CP. Asia Pacific multiple sclerosis consensus. Neurol J Southeast Asia. 1999; 4: 89-90.
7. Kira J, Kanai T, Nishimura Y, et al. Western versus Asian types of multple sclerosis: Immunogenetically and clinically distinct disorders. Ann Neurol. 1996; 40: 569-74.
8. Kuroiwa Y, Hung TP, Landsborough D, Park CS, Signhal BS. Multiple sclerosis in Asia. Neurology. 1997; 27: 188-92.
9. Tan CT, Chong HT. Devic's disease and multiple sclerosis in Asia. Neurol J Southeast Asia. 1999; 4: 57-9.
10. Chong HT, Li PCK, Ong B, Lee KH, Tsai CP, Singhal BS, Prayoonwiwat N, Tan CT. Severe spinal cord involvement is a universal feature of Asians with multiple sclerosis: A joint Asian study. Neurol J Southeast Asia. 2002; 7: 35-40.
11. Barkhof F, Filippi M, Miller DH. Comparison of MR imaging criteria at first presentation to predict conversion to clinically definite MS. Brain. 1997; 120: 2059-69.
12. McDonald WI, Alistair C. Recommended diagnostic criteria for multiple sclerosis Guideline from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol. 2001; 50: 121-7.
13. Poser CM, Paty PW, Scheinberg L. New diagnostic criteria for multiple sclerosis: guideline for research protocols. Ann Neurol. 1983; 13: 227-31.
14. Fukazawa T, Kikuchi S, Niino M, Yabe I, Hamada T, Tashiro K. Multiphasic demyelinating disorder with acute transverse myelitis in Japanese. J Neurol. 2003; 250: 624-6.
15. Kim KK. Idiopathic recurrent transverse myelitis. Arch Neurol. 2003; 60: 1290-4.
16. Kuroiwa Y. Neuromyelitis optica (Devic's disease, Devic's syndrome). In: Koetsier JC, ed: Handbook of Clinical Neurology Vol 3 (47): Demyelinating disease. Elsevier Science Publishers B.V. 1985:397-408.
17. Kurtzke JE. Rating neurological impairment in multiple sclerosis and expanded disability status scale (EDSS). Neurology. 1983; 33: 1444-52.
18. Vejjajiva A. Some aspects of multiple sclerosis in Thai patients. In Kuroiwa Y, Kurland LT, eds: Multiple Sclerosis East and West. Fukuoka: Kyushu University Press. 1982: 117-21.
19. Jitpimolmard S, Vejjajiva A. Clinical features and clinical course of multiple sclerosis in Thai patients: a report of 50 cases. J Med Assoc Thai. 1994; 77: 239-43.
20. Vejjajiva A. Multiple sclerosis in Thailand. Neurol J Southeast Asia. 1997; 2: 7-10.
21. Baun HM, Rothschild BB. The incidence and prevalence and the risk of relapse in multiple sclerosis. N Eng J Med. 2001; 344: 319-26.
22. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol. 2003; 2: 117-27.
23. Misu T, Fujihara K, Nakashima I. Pure optic-spinal form of multiple sclerosis in Japan. Brain. 2002; 125: 2460-8.
24. Optic Neuritis Study Group: Visual function 5 years after optic neuritis. experience of the optic neuritis treatment trial. Arch Opthalmol. 1997; 115: 1545-52.
25. Optic Neuritis Study Group: The 5 years risk of MS after optic neuritis. experience of the optic neuritis treatment trial. Neurology. 1997; 49: 1404-13.
26. Weinshenker BG. Neuromyelitis optica: What it is and what it might be. Lancet. 2003; 361: 889-90.
27. Shibasaki H, Kuroiwa Y. Painful tonic seizure in multiple sclerosis. Arch Neurol. 1974; 30: 47-51.
28. Francis GS, Evans AC, Arnold DL. Neuroimaging in multiple sclerosis. Neurol Clin. 1995; 13: 147-71.
29. Tintore' M, Rovira A, Marty'nez M J, et al. Isolated demyelinating syndromes: Comparison of different imaging criteria to predict conversion to clinically definite MS. Am J Radiology. 2000; 21: 702-6.
30. Chong HT, Ramli N, Lee KH, et al. Magnetic resonance imaging of Asians with multiple sclerosis was similar to that of the West. Neurol Asia. 2004; 9: 47-53.
31. Nakashima I, Fujihara K, Misu T, Fujimori J, Sato S. A comparative study of Japanese multiple sclerosis patients with and without oligoclonal IgG bands. Mult Scler. 2002; 8: 459-62.
32. Jacobs LD, Cookfair DL, Rudick RA. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Ann Neurol. 1996; 39: 285-94.
33. PRISMS Study Group and the University of British Columbia MS/MRI Analysis Group: Long term efficacy of interferon beta-1a in relapsing remitting multiple sclerosis. Neurology. 2001; 56: 1628-36.
34. PRISMS Study Group. Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing remitting multiple sclerosis. Lancet. 1998; 352: 1498-504.
35. Goodin DS, Frohman EM, Garmany GP, et al. Disease modifying therapies in multiple sclerosis. Neurology. 2002; 58: 169-78.
36. Saida T, Tashiro K, Itoyama Y, et al. Interferon beta-1b is effective in Japanese RRMS patients: a randomized, multicenter study. Neurology. 2005; 64: 621-30.
37. Ashtari F, Chitsaz A, Khorvash F, Shaygannejad V. Efficacy of interferon beta-1a in Iranian multiple sclerosis. Neurol Asia. 2005; 10: 109-12.